Christine Duthoit PhD

Dr. Christine Duthoit is the CEO and CSO of RNAlead, a company dedicated to advancing and commercializing FlashRNA, a disruptive RNA delivery technology originally developed and patented at Flash Therapeutics. With over 16 years of experience at Flash Therapeutics before leading RNAlead, she has been instrumental in shaping and improving innovative RNA-based delivery platforms for diverse therapeutic applications.
Christine brings a strong scientific background, holding a Ph.D. and research experience in France and the United States, with a career-long passion for immunology and autoimmune diseases. She has been at the forefront of emerging immunotherapy strategies, recognizing their transformative potential not only in oncology but also across multiple therapeutic areas. A committed leader and innovator, Christine combines deep scientific expertise with operational acumen to drive the development of groundbreaking RNA delivery technologies aimed at addressing some of today’s most pressing therapeutic challenges.